Calcitonin
<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns="http://www.w3.org/TR/REC-html40">
<head> <meta name=Title content=β2-micoglobulin> <meta name=Keywords content=""> <meta http-equiv=Content-Type content="text/html; charset=macintosh"> <meta name=ProgId content=Word.Document> <meta name=Generator content="Microsoft Word 11"> <meta name=Originator content="Microsoft Word 11"> <link rel=File-List href="cal_files/filelist.xml"> <title>β2-micoglobulin</title> <style> </style> </head>
<body bgcolor=white lang=EN-US style='tab-interval:.5in'>
<![if !supportEmptyParas]> <![endif]><o:p></o:p>
Calcitonin<o:p></o:p>
Protein Concentration: 15μM
Cells: PC12 cells
Protocol:
- Incubate calcitonin in MiliQ water at a concentration of 1.5 mM for 24 h prior to adding to the cells. The protein is very soluble at this concentration.
- Dilute this solution to 150 μM in differential media after 24h and add 10 μl of this solution to the cells.
- Incubate for 24h and do the MTT assay.
- If you want to do dose dependence with a drug, prepare the dilutions of the drug in the media in 70 μl volume (for 6 replicates). Add 70 μl of 150 μM calcitonin to the drug solution. Take out 10 μl of media from the plated cells and add 20 μl of the peptide+ drug to the cells (6 replicates). Do MTT/LDH as required.
- The viability of 15μM calcitonin is ~70-80% by MTT assay
<![if !supportEmptyParas]> <![endif]><o:p></o:p>
</body>
</html>
